Organization
Diurnal
4 clinical trials
Clinical trial
A Randomized, Double-Blind, Active-Controlled, Phase 3 Study of Chronocort Compared With Immediate-Release Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaStatus: Completed, Estimated PCD: 2024-02-02
Clinical trial
A Phase 3 Open-Label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over With Congenital Adrenal HyperplasiaStatus: , Estimated PCD: 2024-12-31
Clinical trial
A Phase III Extension Study of Efficacy, Safety and Tolerability of Chronocort® in the Treatment of Congenital Adrenal HyperplasiaStatus: Completed, Estimated PCD: 2022-07-13
Clinical trial
A Double-Blind, Double-Dummy, Two-Way Cross-Over, Randomised, Phase II Study of Efficacy, Safety and Tolerability of Modified-Release Hydrocortisones: Chronocort® Versus Plenadren®, in Adrenal InsufficiencyStatus: Active (not recruiting), Estimated PCD: 2023-10-21